Sixteen months after partnering with Tubulis, Gilead has decided to acquire the biotech and its portfolio of ADCs.

Digital predictive modeling is being used to simulate extreme distribution conditions and prioritize mitigation, but hybrid ...

New US pharmaceutical tariffs reach up to 100%, with exemptions for companies that strike pricing deals or commit to domestic manufacturing.

Lilly’s product, known under the brand name Foundayo, has a clear route to early blockbuster status.

Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of ...

TCW funds, an investment management company, released its “TCW Relative Value Mid Cap Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equities finished the year ...

Amcor, Aptar Group, CCL Industries, Gerresheimer AG, Schott AG, SGD Pharma, West Pharmaceutical Services — are examined.

By Sam Tabahriti, Maggie Fick and Bhanvi Satija LONDON, April 2 (Reuters) - Britain has finalised a U.S.-UK pharmaceutical ...

Intensifying pipeline competition and shorter differentiation windows demand faster, higher-precision launch decisions as most products fail to reach “international excellence” and many generate ...

Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme" or the "Company") today announced its wholly-owned subsidiary, Halozyme ...

GE HealthCare is set to release its first-quarter results later this month, with analysts forecasting a single-digit rise in ...

Bright Path, a U.S.-based advanced pharmaceutical manufacturer, today welcomed President Trump's proclamation imposing tariffs of up to 100 percent on imported patented pharmaceuticals and active ...